Protection of vincristine-induced neuropathy by WldS expression and the independence of the activity of Nmnat1

Neuroscience Letters

Volumn 411, Issue 3, 2007, Pages 228-232

  Watanabe, Masashi ^a   Tsukiyama, Tadasuke ^a   Hatakeyama, Shigetsugu ^a  

^a HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

E4B; Nmnat1; Vincristine; Wallerian degeneration; WldS

Indexed keywords

HYBRID PROTEIN; NICOTINAMIDE MONONUCLEOTIDE ADENYLYLTRANSFERASE 1; NICOTINAMIDE NUCLEOTIDE ADENYLYLTRANSFERASE; WALLERIAN DEGENERATION PROTEIN;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; IN VITRO STUDY; MOUSE; NERVE CELL DIFFERENTIATION; NERVE DEGENERATION; NERVE FIBER DEGENERATION; NEURITE; NEUROPATHY; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; STATISTICAL SIGNIFICANCE;

ANIMALS; BLOTTING, WESTERN; CELL DIFFERENTIATION; CELL LINE; DRUG INTERACTIONS; MICE; NERVE TISSUE PROTEINS; NEURITES; NEURONS; NEUROTOXINS; NICOTINAMIDE-NUCLEOTIDE ADENYLYLTRANSFERASE; TRANSFECTION; TRETINOIN; VINCRISTINE;

EID: 34248326172     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2006.09.068     Document Type: Article

References (22)

1. Araki T., Sasaki Y., and Milbrandt J. Increased nuclear NAD biosynthesis and SIRT1 activation prevent axonal degeneration. Science 305 (2004) 1010-1013
2. S) mouse. Proc. Natl. Acad. Sci. U.S.A. 95 (1998) 9985-9990
3. Coleman M.P., and Perry V.H. Axon pathology in neurological disease: a neglected therapeutic target. Trend. Neurosci. 25 (2002) 532-537
4. S to delay Wallerian degeneration. Cell Death Differ. (2006)
5. S) mouse. Proc. Natl. Acad. Sci. U.S.A. 97 (2000) 11377-11382
6. Deckwerth T.L., and Johnson Jr. E.M. Neurites can remain viable after destruction of the neuronal soma by programmed cell death (apoptosis). Dev. Biol. 165 (1994) 63-72
7. Ferri A., Sanes J.R., Coleman M.P., Cunningham J.M., and Kato A.C. Inhibiting axon degeneration and synapse loss attenuates apoptosis and disease progression in a mouse model of motoneuron disease. Curr. Biol. 13 (2003) 669-673
8. Finn J.T., Weil M., Archer F., Siman R., Srinivasan A., and Raff M.C. Evidence that Wallerian degeneration and localized axon degeneration induced by local neurotrophin deprivation do not involve caspases. J. Neurosci. 20 (2000) 1333-1341
9. Gillingwater T.H., Wishart T.M., Chen P.E., Haley J.E., Robertson K., MacDonald S.H., Middleton S., Wawrowski K., Shipston M.J., Melmed S., Wyllie D.J., Skehel P.A., Coleman M.P., and Ribchester R.R. The neuroprotective WldS gene regulates expression of PTTG1 and erythroid differentiation regulator 1-like gene in mice and human cells. Hum. Mol. Genet. 15 (2006) 625-635
10. S, binds directly to VCP/p97 and partially redistributes it within the nucleus. Mol. Biol. Cell 17 (2006) 1075-1084
11. Lunn E.R., Perry V.H., Brown M.C., Rosen H., and Gordon S. Absence of Wallerian degeneration does not hinder regeneration in peripheral nerve. Eur. J. Neurosci. 1 (1989) 27-33
12. Mack T.G., Reiner M., Beirowski B., Mi W., Emanuelli M., Wagner D., Thomson D., Gillingwater T., Court F., Conforti L., Fernando F.S., Tarlton A., Andressen C., Addicks K., Magni G., Ribchester R.R., Perry V.H., and Coleman M.P. Wallerian degeneration of injured axons and synapses is delayed by a Ube4b/Nmnat chimeric gene. Nat. Neurosci. 4 (2001) 1199-1206
13. S, inhibits axonal spheroid pathology in gracile axonal dystrophy mice. Brain 128 (2005) 405-416
14. Okumura F., Hatakeyama S., Matsumoto M., Kamura T., and Nakayama K.I. Functional regulation of FEZ1 by the U-box-type ubiquitin ligase E4B contributes to neuritogenesis. J. Biol. Chem. 279 (2004) 53533-53543
15. S). Eur. J. Neurosci. 7 (1995) 1641-1650
16. Sagot Y., Dubois-Dauphin M., Tan S.A., de Bilbao F., Aebischer P., Martinou J.C., and Kato A.C. Bcl-2 overexpression prevents motoneuron cell body loss but not axonal degeneration in a mouse model of a neurodegenerative disease. J. Neurosci. 15 (1995) 7727-7733
17. S-mediated protection of dopaminergic fibers in an animal model of Parkinson disease. Curr. Biol. 14 (2004) 326-330
18. S mutation delays robust loss of motor and sensory axons in a genetic model for myelin-related axonopathy. J. Neurosci. 23 (2003) 2833-2839
19. S does not attenuate mutant SOD1-mediated motor neuron disease. Neuromol. Med. 5 (2004) 193-203
20. Wang J., Zhai Q., Chen Y., Lin E., Gu W., McBurney M.W., and He Z. A local mechanism mediates NAD-dependent protection of axon degeneration. J. Cell Biol. 170 (2005) 349-355
21. S mice are resistant to paclitaxel (taxol) neuropathy. Ann. Neurol. 52 (2002) 442-447
22. S protein protects against axonal degeneration: a model of gene therapy for peripheral neuropathy. Ann. Neurol. 50 (2001) 773-779